All In Biotech

Drug Trial Radar · NCT02747927

Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children

Phase III, Double-Blind, Randomized, Placebo-Controlled Trial to Investigate the Efficacy, Safety and Immunogenicity of a Tetravalent Dengue Vaccine (TDV) Administered Subcutaneously in Healthy Children Aged 4 - 16 Years Old

Last checked: Nov 19, 2026Latest source record: Nov 19, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 20,099 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

20,099

Actual

Start

Apr 26, 2016

Primary completion

Jul 11, 2018

Study completion Jun 28, 2024

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Apr 22, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 4 years, up to 16 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy of 2 doses of Tetravalent Dengue Vaccine Candidate (TDV) in preventing symptomatic dengue fever of any severity and due to any of the four dengue virus serotypes in 4 to 16 year old participants.

Conditions

  • Healthy Volunteers

Interventions

  • PlaceboDrug

    TDV placebo-matching SC injection.

  • Tetravalent Dengue Vaccine (TDV)Biological

    TDV SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Vaccine Efficacy (VE) of Two Doses of Tetravalent Dengue Vaccine Candidate (TDV) in Preventing Virologically-Confirmed Dengue Fever Induced by Any Dengue SerotypeTime frame: 30 days post-second vaccination (Day 120 [Month 4]) until the end of Part 1 (Month 15) when at least 120 cases of dengue fever were confirmed and minimum duration of participant follow-up was 12 months post-second vaccination

Locations

28 sites in 8 countries. Site status is shown where the registry gives one.

  • Universidade Federal Do Espirito Santo Hospital Universitario Cassiano Antonio de Moraes HUCAM

    Vitória, Espírito Santo, Brazil

  • Associacao Obras Sociais Irma Dulce Hospital Santo Antonio

    Salvador, Estado de Bahia, Brazil

  • Universidade Federal de Mato Grosso do Sul

    Campo Grande, Mato Grosso do Sul, Brazil

  • Centro de Estudos e Pesquisa em Molestias Infecciosas LTDA (CPCLIN)

    Cidade Alta, Natal - RN, Brazil

  • Centro de Atencion e Investigacion Medica S.A - CAIMED - Aguazul - PPDS-PV

    Aguazul, Casanare Department, Colombia

  • Centro de Atencion e Investigacion Medica S.A - CAIMED - Yopal - PPDS-PV

    Yopal, Casanare Department, Colombia

  • Centro de Atencion e Investigacion Medica S.A. - CAIMED - Acacias - PPDS-PV

    Acacías, Meta Department, Colombia

  • Centro de Estudios em Infectologia Pediatrica SAS (CEIP S.A.S)

    Cali, San Fernando, Colombia

  • Hospital Maternidad Nuestra Senora de Altagracia

    Santo Domingo, Distrito Nacional Santo Domingo, Dominican Republic

  • Calle Alexander Fleming No. 90 Esquina 37, Ensanche La Fe

    Santo Domingo, Distrito Nacional Santo Domingo, Dominican Republic

  • Universidad Nacional Autonoma de Nicaragua

    León, Nicaragua

  • Centro De Vacunacion Internacional, S.A. (Cevaxin)

    Panama City, Panama

  • Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede 24 de Diciembre

    Panama City, Panama

  • Centro De Vacunacion Internacional, S.A. (Cevaxin) Sede Plaza Carolina

    Panama City, Panama

  • Centro De Vacunacion Internacional, S.A.(Cevaxin) - La Chorrera

    Panama City, Panama

  • Research Institute for Tropical Medicine

    City of Muntinlupa, Philippines

  • University of the Philippine Manila

    Ermita, Philippines

  • Las Pinas Health Center A

    Las Piñas, Philippines

  • Las Pinas Health Center D

    Las Piñas, Philippines

  • Dela Salle Health Sciences Institute

    Dasmariñas, Cavite, Philippines

  • Philippines-AFRIMS Virology Research Unit

    Cebu City, Cebu, Philippines

  • Lady Ridgeway Hospital for Children

    Colombo, Sri Lanka

  • Colombo South Teaching Hospital

    Dehiwala, Sri Lanka

  • Negombo General Hospital

    Negombo, Sri Lanka

  • Colombo North Teaching Hospital

    Ragama, Sri Lanka

  • Srinagarind Hospital

    Khon Kaen, Thailand

  • The Hospital for Tropical Diseases

    Bangkok, Bangkok, Thailand

  • Phramongkutklao Hospital

    Bangkok, Bangkok, Thailand

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.